SARS-CoV-2 Positivity Not Linked to New Asthma Diagnosis in Children
By Elana Gotkine HealthDay Reporter
FRIDAY, April 12, 2024 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) positivity in children is not associated with an increased risk for new asthma diagnosis, according to a study published online April 12 in Pediatrics.
James P. Senter, M.D., M.P.H., from the Children's Hospital of Philadelphia, and colleagues conducted a retrospective cohort study involving children ages 1 to 16 years who received PCR testing for SARS-CoV-2 between March 1, 2020, and Feb. 28, 2021. The hazard ratio for new asthma diagnosis was compared between SARS-CoV-2 PCR-positive and negative groups within an 18-month observation period.
The study included 27,423 individuals. The researchers found that SARS-CoV-2 PCR positivity had no significant effect on new asthma diagnosis, while Black race, food allergies, and allergic rhinitis significantly increased the risk for new asthma diagnosis (hazard ratios, 1.49, 1.26, and 2.30, respectively). For children younger than 5 years, preterm birth and body mass index significantly increased the risk for new asthma diagnosis (hazard ratios, 1.48 and 1.13, respectively).
"SARS-CoV-2 PCR positivity does not confer an additional risk for asthma diagnosis, at least within the first 18 months after PCR test," the authors write. "This information may be useful for families and providers alike in the prognostication of the long-term respiratory effects after SARS-CoV-2 infection in children."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Further Support and Information on COVID-19
Read this next
Few Adults With Moderate, Severe Asthma Receive Recommended Inhaler Regimen
THURSDAY, May 23, 2024 -- Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended Single Maintenance and Reliever Therapy (SMART) inhaler...
Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season
WEDNESDAY, May 22, 2024 -- In fall/winter 2023/2024, the risk for death in patients hospitalized for COVID-19 was greater than the risk for death in patients hospitalized for...
Global Life Expectancy, Disease Burden Set to Keep Improving
WEDNESDAY, May 22, 2024 -- Life expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.